BAM
HALO icon

Byrne Asset Management’s Halozyme HALO Stock Holding History

Byrne Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.55K Hold
80
– – ﹤0.01% 461
2026
Q2 		$6.26K Buy
+80
New +$5.46K ﹤0.01% 478
2025
Q3 		– Sell
-190
Closed -$9.88K – 579
2025
Q2 		$9.88K Hold
190
– – 0.01% 399
2025
Q1 		$12.1K Buy
+190
New +$11K 0.01% 395

Other funds holding HALO

CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MAG
MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return
CFO
Collective Family Office York, Pennsylvania $484M AUM 13.93% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return

Byrne Asset Management's HALO Position: Q3 2026 in Review

Byrne Asset Management held its Halozyme (HALO) position steady in Q3 2026 at 80 shares worth $8.55K. The position accounts for ﹤0.01% of the portfolio, ranked #461.

Byrne Asset Management first reported a position in HALO in Q1 2025 and has held it in 4 quarters since. The position peaked at $12.1K in Q1 2025. 31 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Byrne Asset Management held 80 shares of Halozyme worth $8.55K as of Q3 2026.
  • Byrne Asset Management left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up ﹤0.01% of Byrne Asset Management's portfolio in Q3 2026, its #461 holding.
  • Byrne Asset Management first reported a position in Halozyme in Q1 2025 and has held it in 4 quarters since.
  • Byrne Asset Management's Halozyme position peaked at $12.1K in Q1 2025.
  • 31 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Byrne Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.